JP2007510403A5 - - Google Patents

Download PDF

Info

Publication number
JP2007510403A5
JP2007510403A5 JP2006534768A JP2006534768A JP2007510403A5 JP 2007510403 A5 JP2007510403 A5 JP 2007510403A5 JP 2006534768 A JP2006534768 A JP 2006534768A JP 2006534768 A JP2006534768 A JP 2006534768A JP 2007510403 A5 JP2007510403 A5 JP 2007510403A5
Authority
JP
Japan
Prior art keywords
isoleucine
seq
use according
polypeptide further
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006534768A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007510403A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/052572 external-priority patent/WO2005037305A1/en
Publication of JP2007510403A publication Critical patent/JP2007510403A/ja
Publication of JP2007510403A5 publication Critical patent/JP2007510403A5/ja
Pending legal-status Critical Current

Links

JP2006534768A 2003-10-16 2004-10-18 ケモカイン変異体の治療への使用 Pending JP2007510403A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03078308 2003-10-16
PCT/EP2004/052572 WO2005037305A1 (en) 2003-10-16 2004-10-18 Therapeutic uses of chemokine variants

Publications (2)

Publication Number Publication Date
JP2007510403A JP2007510403A (ja) 2007-04-26
JP2007510403A5 true JP2007510403A5 (enExample) 2007-12-06

Family

ID=34442986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006534768A Pending JP2007510403A (ja) 2003-10-16 2004-10-18 ケモカイン変異体の治療への使用

Country Status (16)

Country Link
US (1) US7740833B2 (enExample)
EP (1) EP1673103A1 (enExample)
JP (1) JP2007510403A (enExample)
KR (1) KR20070008510A (enExample)
CN (1) CN1867352A (enExample)
AR (1) AR046594A1 (enExample)
AU (1) AU2004281552B2 (enExample)
BR (1) BRPI0415290A (enExample)
CA (1) CA2536082A1 (enExample)
EA (1) EA009414B1 (enExample)
IL (1) IL175020A0 (enExample)
MX (1) MXPA06003695A (enExample)
NO (1) NO20062109L (enExample)
UA (1) UA91820C2 (enExample)
WO (1) WO2005037305A1 (enExample)
ZA (1) ZA200601900B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713521B2 (en) * 2005-08-12 2010-05-11 Schering Corporation MCP1 fusions
EP2007815A2 (en) * 2006-03-31 2008-12-31 Biotherapix Molecular Medicines S.L.U. Mono- and bifunctional molecules with ability to bind to g protein-coupled receptors
US20100166733A1 (en) * 2006-06-21 2010-07-01 Zurit Levin Mcp-1 splice variants and methods of using same
EP2056857B1 (en) * 2006-07-24 2013-08-21 Yeda Research And Development Co. Ltd. Pharmaceutical compositions comprising ccl2 for use in the treatment of inflammation
US20080076120A1 (en) * 2006-09-14 2008-03-27 Millennium Pharmaceuticals, Inc. Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders
US20120046218A1 (en) * 2009-01-30 2012-02-23 Protaffin Biotechnologie Ag Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
US8524217B2 (en) 2010-05-11 2013-09-03 Merck Sharp & Dohme Corp. MCP1-Ig fusion variants
AU2012262491A1 (en) * 2011-06-01 2014-01-16 Jyant Technologies Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
US9249204B2 (en) 2011-06-01 2016-02-02 Jyant Technologies, Inc. Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
US8796422B2 (en) * 2011-06-01 2014-08-05 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
DK2718311T3 (en) * 2011-06-13 2018-04-16 Tla Targeted Immunotherapies Ab TREATMENT OF MULTIPLE SCLEROSIS
US9726666B2 (en) 2011-06-13 2017-08-08 Tla Targeted Immunotherapies Ab Diagnosing and treating inflammatory diseases
ES2764840T3 (es) 2015-01-28 2020-06-04 Univ Bordeaux Uso de plerixafor para tratar y/o prevenir exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica
CN107207603A (zh) * 2015-02-03 2017-09-26 吉安特科技股份有限公司 趋化因子‑免疫球蛋白融合多肽,其组合物、制备方法以及用途
CA3046489A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
EP3554541B1 (en) 2016-12-14 2023-06-07 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
KR102066149B1 (ko) * 2018-08-17 2020-01-14 고려대학교 산학협력단 Ccl2를 유효성분으로 포함하는 임신촉진용 조성물
CN116726361A (zh) 2018-11-19 2023-09-12 比奥拉治疗股份有限公司 用生物治疗剂治疗疾病的方法和装置
WO2021119482A1 (en) 2019-12-13 2021-06-17 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU687872B2 (en) * 1993-09-14 1998-03-05 Imperial College Of Science, Technology And Medicine Eotaxin: eosinophil chemotactic cytokine
US5459128A (en) * 1993-11-12 1995-10-17 Dana-Farber Cancer Institute Human monocyte chemoattractant protein-1 (MCP-1) derivatives
US5739103A (en) * 1993-11-12 1998-04-14 Dana-Farber Cancer Institute Chemokine N-terminal deletion mutations
JP3837748B2 (ja) * 1997-01-17 2006-10-25 東亞合成株式会社 Vegf結合性ポリペプチド
US6100387A (en) * 1997-02-28 2000-08-08 Genetics Institute, Inc. Chimeric polypeptides containing chemokine domains
US6617135B1 (en) * 1999-08-09 2003-09-09 Emd Lexigen Research Center Corp. Multiple cytokine protein complexes
US7332474B2 (en) * 2001-10-11 2008-02-19 Amgen Inc. Peptides and related compounds having thrombopoietic activity
CA2463003A1 (en) * 2001-10-19 2003-04-24 Zymogenetics, Inc. Dimerized growth factor and materials and methods for producing it
WO2003083059A2 (en) * 2002-03-26 2003-10-09 Centocor, Inc. Mcp-1 mutant proteins, antibodies, compositions, methods and uses
EA200401342A1 (ru) * 2002-04-10 2005-08-25 Апплайд Резеч Системз Арс Холдинг Н. В. Новые антагонисты белков mcp
EP2007815A2 (en) * 2006-03-31 2008-12-31 Biotherapix Molecular Medicines S.L.U. Mono- and bifunctional molecules with ability to bind to g protein-coupled receptors

Similar Documents

Publication Publication Date Title
JP2007510403A5 (enExample)
JP2006006329A5 (enExample)
JP2006524283A5 (enExample)
JP2006503588A5 (enExample)
JP2009542225A5 (enExample)
JP2007508034A5 (enExample)
JP2007525988A5 (enExample)
JP2018186833A5 (enExample)
JP2007520565A5 (enExample)
JP2006511228A5 (enExample)
JP2006508095A5 (enExample)
JP2008542528A5 (enExample)
JP2009501689A5 (enExample)
JP2009504909A5 (enExample)
JP2008519810A5 (enExample)
JP2008024962A5 (enExample)
JP2008533990A5 (enExample)
JP2003284553A5 (enExample)
JP2007508806A5 (enExample)
JP2009509934A5 (enExample)
JP2005531640A5 (enExample)
JP2008545704A5 (enExample)
沈伯俊 Some Remarks on the Novel Stories of the Three Kingdoms
RU2004132147A (ru) Адаптоген
CN300766503S (zh) 铁道整体腕臂绝缘子